Discovery of 3-Phenyl Indazole-Based Novel Chemokine-Like Receptor 1 Antagonists for the Treatment of Psoriasis

In the imiquimod-induced psoriasis-like mouse model, oral administration of the optimized compound for one week significantly alleviated modified psoriasis area and severity index scores, compared with the control group.